Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Mental Health America Honors Senators Edward M. Kennedy, Pete Domenici For Mental Health Leadership
Mental Health America, celebrating its 100th Anniversary as the founder of the organized mental health movement, will honor Senators Edward M. Kennedy and Pete Domenici for their legendary work on behalf of individuals with mental health conditions at its Centennial Gala on Thursday, June 11, in Washington, D.C.
generic viagra online
Bausch & Lomb Receives FDA Approval Of Besivance(TM), New Topical Ophthalmic Antibacterial For The Treatment Of Bacterial Conjunctivitis ('Pink Eye')
Bausch & Lomb, a world leader in eye health, announced that the U.S. Food and Drug Administration (FDA) approved Besivance(TM) (besifloxacin ophthalmic suspension) 0.6% for the treatment of bacterial conjunctivitis, commonly referred to as "pink eye." Besivance(TM) is a new topical ophthalmic antibacterial, administered via sterile ophthalmic drops, that treats a wide range of eye pathogens including those that most commonly cause bacterial conjunctivitis.(4) Bacterial conjunctivitis is one of the most common ocular conditions worldwide.(2)
News of the day
Reduced Risk Of Stroke, Further Heart Attack And Death For Patients After A Heart Attack Or Unstable Angina With Oral Rivaroxaban
The findings of the ATLAS ACS-TIMI 46 study are reported in an article Online First and in a future edition of The Lancet, and written by Dr Jessica L Mega, Brigham and Women"s Hospital, Boston, MA, USA, and collaborators. They suggest that the intake of the oral anti-clotting drug rivaroxaban in patients after an acute coronary syndrome (such as a heart attack or an unstable angina) reduces the risk of stroke, another heart attack, and death.
Mental Health

British Medical Association Scotland Calls For An End To The Ridiculous Pricing Of Alcohol

Doctors leaders called for an end to the ridiculous pricing of alcohol for off sales in light of findings from the Scottish Schools Adolescent Lifestyle and Substance Use Survey (SALSUS). The survey shows that 52% of 13 year olds and 82% of 15 year olds have had at least one alcoholic drink and that shops and off-licences were the second most common for purchasing alcohol. Dr Peter Terry, Chairman of BMA Scotland said: "When alcohol is cheaper than bottled water, we have to worry about what message we are sending our children. "Alcohol costs our economy around ÷£1 billion every year, but the human cost is much higher. One death every six hours in Scotland is caused by alcohol. "There is no single solution to Scotland"s alcohol problem, but evidence shows that there is a direct relationship between the price of alcohol and the amount consumed. BMA Scotland supports the introduction of minimum pricing to stop retailers from selling alcohol at very low prices." British Medical Association


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009